Pharmaceuticals

Global Quinolones Market Valuation and Growth Prospects: $63.17 Billion by 2029

December 3, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the quinolones market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Quinolones Market Size?

The quinolones market has observed consistent expansion in its size over recent years. It is anticipated to grow from $50.05 billion in 2024 to $51.89 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 3.7%. The expansion witnessed during the past period stems from elements such as antibiotic demand and utilization, official regulatory clearances, advancements in research and development, the prevailing competitive environment, and the lapsing of patent protections.

The quinolones market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a value of $63.17 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.0%. Factors contributing to this growth during the forecast period include the emergence of new diseases, shifts in regulatory frameworks, global health policy initiatives, increasing antibiotic resistance, and various market expansion strategies. Key trends anticipated within this period encompass the development of new products and modifications to the regulatory landscape.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

What Core Market Drivers Are Expanding The Quinolones Industry?

The increasing occurrence of infectious diseases is significantly fueling the expansion of the quinolones market. These illnesses are caused by microbes such as viruses, bacteria, fungi, and parasites. Quinolones are widely utilized in treating various bacterial infectious diseases, including tuberculosis and urinary tract infections. For instance, in November 2023, the Global Tuberculosis Report, published by the World Health Organization, a Switzerland-based health agency, indicated that the global count of newly diagnosed TB cases reached 7.5 million in 2022, an increase from 6.4 million in 2021. Therefore, the elevated incidence of infectious diseases will propel the quinolones market.

What Segment Insights Are Highlighted In The Quinolones Market Report?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Norfloxacin: Indications, Dosage Forms

2) By Ofloxacin: Indications, Dosage Forms

3) By Ciprofloxacin: Indications, Dosage Forms

4) By Gemifloxacin: Indications, Dosage Forms

5) By Other Types: Various Formulations, Indications

Which Notable Trends Are Transforming The Quinolones Market Outlook?

A significant trend gaining popularity in the quinolones market is product innovation. Major companies operating in the quinolones market are concentrating on developing innovative products to maintain their market position. For instance, in January 2023, the South Korean branch of Viatris, a US-based pharmaceutical company, introduced Dovprela, a new drug-resistant tuberculosis treatment. Dovprela is a three-drug regimen of bedaquiline, pretomanid, and linezolid (BPaL) for treating adult patients with extensively drug-resistant TB and treatment-resistant or non-responsive multidrug-resistant TB. Due to its rapid anti-tuberculosis effect, Dovprela shortens the treatment period from 18-20 months to 5-6 months.

Which Firms Are Driving Innovation Within The Quinolones Market?

Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

What Regional Trends Are Shaping Growth In The Quinolones Market?

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp

Browse Through More Reports Similar to the Global Quinolones Market 2025, By The Business Research Company

Grain Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/grain-products-global-market-report

Grain Farming Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/grain-farming-global-market-report

Grain Alcohol Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/grain-alcohol-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795